The 2016 participants for SWOG‘s Young Investigator Training Course (YITC) to be held in Seattle from Sept. 26-28 were reviewed and selected in late August. The YITC is SWOG’s premier education opportunity for early career investigators, and remains a major way that new trials and new leaders get into SWOG’s network. 
This year’s cohort includes:
Uma M. Borate, MD, MS, Oregon Health & Science University
Phase II Study of Brentuximab Vedotion in Systemic Mastocytosis and Chronic Myelomonocytic Leukemia
Erin F. Cobain, MD, University of Michigan
PeRsistently Elevated CTCs in chemotherapy-refractory metastatic breast cancer treated with combination immune CHEcKpoint inhibition (PRE-CHEK)
Kristen M. O’Dwyer, MD, University of Rochester Medical Center
Treatment Response Adapted Therapy for Adolescents and Young Adults (AYAs) with Acute Myeloid Leukemia
Emma C. Scott, MD, Oregon Health & Science University
A Phase II Study of Isatuximab (SAR650984) for Patients with Previously Treated AL Amyloidosis
Virginia Sun, RN, PhD, City of Hope
A Personalized Dietary Intervention to Manage Bowel Dysfunction in Rectal Cancer Survivors
Cecilia C.S. Yeung, MD, Fred Hutchinson Cancer Research Center
AKR1C3 and POR expression for activation of PR- 104 in Relapsed/ Refractory T-ALL
The SWOG Young Investigator Training Course was launched in 1999. For more information about the course and how to apply visit our program page.
;